LIGAND PHARMACEUTICALS INCORPORATED Non Peo Neo Avg Total Comp Amt
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Non Peo Neo Avg Total Comp Amt of $4.07 million for the 12-month period ending 2025-12-31, per its DEF 14A filed 2026-04-21.
Financial Statements › Notes
ecd:NonPeoNeoAvgTotalCompAmt · last filed 2026-04-21
| Period end | Non Peo Neo Avg Total Comp Amt 12 month |
|---|---|
| 2025-12-31 | $4.07M DEF 14A · filed 2026-04-21 |
| 2024-12-31 | $6.58M DEF 14A · filed 2026-04-21 |
| 2023-12-31 | $2.79M DEF 14A · filed 2026-04-21 |
| 2022-12-31 | $3.85M DEF 14A · filed 2026-04-21 |
| 2021-12-31 | $5.00M DEF 14A · filed 2026-04-21 |